Tamiflu Sales Boost Roche Earnings, As Genentech Merger Is Defended
Executive Summary
Roche executives were on the defensive about the effects of last year's acquisition of Genentech at a Feb. 4 meeting to discuss their 2009 financial results. And there was good reason